Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China

BACKGROUND: The 2021 Chinese Expert Consensus on the Clinical Application of the Human Papillomavirus (HPV) Vaccine recommended vaccination for women who previously received ablative or excisional treatment for high-grade squamous intraepithelial lesion (HSIL). This study evaluates the cost-effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Maosheng, Liu, Hanting, Liu, Huan, Wang, Mengjie, Zou, Zhuoru, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083292/
https://www.ncbi.nlm.nih.gov/pubmed/37051255
http://dx.doi.org/10.3389/fimmu.2023.1119566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083292/
https://www.ncbi.nlm.nih.gov/pubmed/37051255
http://dx.doi.org/10.3389/fimmu.2023.1119566

Ejemplares similares